Assessing the role of lipid-lowering therapy on multi-cancer prevention: A mendelian randomization study
Min Yu(Fudan University), Xingchen Peng(Sichuan University), Yongllin Su(Sichuan University), Ruidan Li(Sichuan University), Xiaolin Hu(Southwest Hospital), Jing Jin(Sichuan University), Xiaoyuan Wei(Sichuan University), Yiyan Pei(Sichuan University), Zhigong Wei(North Sichuan Medical University), Zheran Liu(Sichuan University)
Cited by 9
Related Papers
Prognostic effect of triglyceride glucose-related parameters on all-cause and cardiovascular mortality in the United States adults with metabolic dysfunction-associated steatotic liver disease
|Cardiovascular Diabetology|2024|72
A novel bispecific c-MET/PD-1 antibody with therapeutic potential in solid cancer
|Oncotarget|2017|40
Hepatitis B virus infection: An insight into the clinical connection and molecular interaction between hepatitis B virus and host extrahepatic cancer risk
|Frontiers in Immunology|2023|40
Survival outcomes following treatment delays among patients with early-stage female cancers: a nationwide study
|Journal of Translational Medicine|2022|32
Prognostic nomogram for adenoid cystic carcinoma in different anatomic sites
|Head & Neck|2020|29